Table 2.

Health Characteristics by Group for 181 Children at Follow-up

Characteristic	CON Group (n = 86)*	INT Group (n = 95)*	Total (N = 181)*	Statistic†
Asthma morbidity and mortality over 12-mo follow-up
Severity at 12 mo‡
Mild persistent	57 (66.3)	60 (63.2)	117 (64.6)	1.07 (0.93–1.22)
Moderate persistent	7 (8.1)	13 (13.7)	20 (11.0)	0.96 (0.50–1.83)
Severe persistent	15 (17.4)	10 (10.5)	25 (13.8)	1.50 (0.87–2.57)
Death	1 (1.2)	2 (2.1)	3 (1.7)	0.50 (0.05–5.39)
Health care use over 12-mo follow-up
Health insurance, medical assistance	70 (81.4)	78 (82.1)	148 (81.8)	0.98 (0.86–1.12)
Specialty care in the past 12 mo	43 (50.0)	37 (38.9)	80 (44.2)	1.28 (0.92–1.78)
Hospitalized in the past 6 mo (≥1 time)	11 (12.8)	4 (4.2)	15 (8.3)	3.03 (1.00–9.18)
ED visit in the past 6 mo (≥1 time)	40 (46.5)	27 (28.4)	67 (37.0)	1.60 (1.08–2.37)
No. of nonurgent clinic visits for asthma in the past 6 mo	1.85 (1.20–2.49)§	2.36 (1.26–3.46) §	2.11 (4.40) ||	t Test = 0.78, P =.44
Asthma medication prescriptions over 12-mo follow-up
No. of short-acting 3-agonist prescriptions (quick relief ) (range, 0–26)	3.88 (2.94–4.82) §	3.40 (2.74–4.06) §	3.65 (3.83) ||	z = 0.50, P =.61¶
No. of oral corticosteroid prescriptions (quick relief ) (range, 0–8)	1.20 (0.88–1.52) §	1.16 (0.84–1.48) §	1.20 (1.50) ||	z = 0.48, P =.63¶
No. of inhaled corticosteroid prescriptions (range, 0–14)	3.30 (2.64–3.96) §	2.47 (1.84–3.11) §	2.90 (3.10) ||	z = 2.38, P =.02¶

Abbreviations: See Table 1.

^*Data are given as number (percentage) of each group unless otherwise indicated.

^†Data are given as relative risk (95% confidence interval) unless otherwise indicated.

^‡Reference includes mild intermittent severity.

^§Data are given as mean (95% confidence interval).

^||Data are given as mean (SD).

^¶Two-sided Wilcoxon rank sum test.